PPARα gene variation and physical performance in Russian athletes

European Journal of Applied Physiology

Volumn 97, Issue 1, 2006, Pages 103-108

  Ahmetov, Ildus I ^a   Mozhayskaya, Irina A ^a   Flavell, David M ^b   Astratenkova, Irina V ^a   Komkova, Antonina I ^a   Lyubaeva, Ekaterina V ^c   Tarakin, Pavel P ^c   Shenkman, Boris S ^c   Vdovina, Anastasia B ^c   Netreba, Aleksei I ^c   Popov, Daniil V ^c   Vinogradova, Olga L ^c   Montgomery, Hugh E ^b   Rogozkin, Viktor A ^a  

^a St Petersburg Research Institute of Physical Culture   (Russian Federation)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c INSTITUTE OF BIOMEDICAL PROBLEMS   (Russian Federation)

Author keywords

Fatty acids; Muscle fiber type; Physical performance; Polymorphism; PPAR

Indexed keywords

FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ANAEROBIC CAPACITY; ARTICLE; ATHLETE; CELL COMPOSITION; CELL TYPE; COHORT ANALYSIS; CONTROLLED STUDY; ENDURANCE SPORT; FATTY ACID METABOLISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRON; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE FORCE; MUSCLE METABOLISM; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SLOW MUSCLE FIBER; STATISTICAL SIGNIFICANCE; VASTUS LATERALIS MUSCLE; CLINICAL TRIAL; CYTOLOGY; ENDURANCE; GENETICS; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SKELETAL MUSCLE; SPORT; STATISTICS;

ADULT; FEMALE; HUMANS; MALE; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; PPAR ALPHA; PSYCHOMOTOR PERFORMANCE; RUSSIA; SPORTS; VARIATION (GENETICS);

EID: 33745436772     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-006-0154-4     Document Type: Article

References (18)

1. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD (1994) Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol Heart Circ Physiol 267:742-750
2. Aoyama T, Peters JM, Iritani N, et al. (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273:5678-5684
3. Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP (2000) Deactivation of peroxisome proliferator-activated receptor α during cardiac hypertrophic frowth. J Clin Invest 105:1723-1730
4. Bolla MK, Haddad L, Humphries SE, Winder AF, Day INM (1995) A method of determination of hundreds of APOE genotypes utilizing highly simplified, optimized protocols and restriction digestion analysis by microtitre array diagonal gel electrophoresis (MADGE). Clin Chem 41:1599-1604
5. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137:354-366
6. Brooks GA, Mercier J (1994) Balance of carbohydrate and lipid utilization during exercise: The crossover concept. J Appl Physiol 76:2253-2261
7. Cresci S, Wright LD, Spratt JA, Briggs FN, Kelly DP (1996) Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle. Am J Physiol Cell Physiol 270:1413-1420
8. Flavell DM, Ireland H, Stephens JW et al (2005) Peroxisome proliferator-activated receptor α gene variation influences age of onset and progression of type 2 diabetes. Diabetes 54:582-586
9. Flavell DM, Jamshidi Y, Hawe E et al (2002) Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 105:1440-1445
10. Flavell DM, Pineda Torra I, Jamshidi Y et al (2000) Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 43:673-680
11. Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ et al (2004) Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron 7 polymorphism in subjects with type 2 diabetes. Pharmacogenetics 14(12):823-829
12. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP (1994) The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91:11012-11016
13. Horowitz JF, Leone TC, Feng W, Kelly DP, Klein S (2000) Effect of endurance training on lipid metabolism in women: A potentional role for PPARα in the metabolic response to training. Am J Physiol Endocrinol Metab 279:348-355
14. Jamshidi Y, Montgomery HE, Hense H-W et al (2002) Peroxisome proliferator-activated receptor α gene regulates left ventricular growth in response to exercise and hypertension. Circulation 105:950-955
15. Kagaya Y, Kanno Y, Takeyama D et al (1990) Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. Circulation 81:1353-1361
16. Russel AP, Feilchenfeldt Y, Schreiber S et al (2003) Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 52:2874-2881
17. Schmitt B, Fluck M, Decombaz J (2003) Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. Physiol Genom 15:148-157
18. Vohl M-C, Lepage P, Gaudet D et al (2000) Molecular scanning of the human PPARα gene: Association of the L162V mutation with hyperapobetalipoproteinemia. J Lipid Res 41:945-952